Verona Pharma Plc (DELISTED) (VRNA:DL)
106.91
0.00 (0.00%)
USD |
NASDAQ |
Oct 16, 16:00
Verona Pharma Total Assets (Quarterly): 572.87M for June 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Merck & Co., Inc. | 129.55B |
| AstraZeneca PLC | 114.46B |
| GSK Plc | 82.58B |
| Haleon Plc | -- |
| Adaptimmune Therapeutics Plc | 130.63M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 294.60M |
| Shareholders Equity (Quarterly) | 278.27M |
| Debt to Equity Ratio | 0.8782 |
| Current Ratio | 10.71 |
| Net Debt Paydown Yield | -0.47% |